Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. (Q44399938)

From Wikidata
Jump to navigation Jump to search
scientific article published in April 2003
edit
Language Label Description Also known as
English
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
scientific article published in April 2003

    Statements

    Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3. (English)
    Kevin J Blinder
    Mark S Blumenkranz
    Guy Donato
    Hilel Lewis
    Jennifer I Lim
    Ugo Menchini
    Jordi M Mones
    Michael J Potter
    Constantin Pournaras
    Al Reaves
    Philip Rosenfeld
    Andrew P Schachat
    Michel Sickenberg
    Lawrence J Singerman
    Jason S Slakter
    H Andrew Strong
    George A Williams
    1 April 2003
    667-673

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit